Cara Therapeutics, Inc. (0HTC.L) LSE

15.99

-0.7893(-4.70%)

Updated at September 02 02:58PM

Currency In USD

Valuation

Market Cap7.45M
Enterprise Value14M
P/E Ratio-2.81
PEG Ratio-0.05
Price/Sales Ratio9.75
Price/Book Ratio1.41
Enterprise/Revenue4.48
Enterprise/EBITDA-0.83

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-3.47
Operating Margin-5.76

Management Effectiveness

Return On Assets-0.36
Return On Equity-1.16

Income Statement

Revenue7.14M
Revenue/Share0.43
Gross Profit6.33M
EBITDA-62.6M
Net Income-70.87M
Diluted EPS-46.59

Balance Sheet

Total Cash36.46M
Total Cash/Share3.89
Total Debt228,000
Total Debt/Equity0.01
Current Ratio3.48
Book Value Per Share2.97

Price History

52-Week Change359.48
52-Week High15.99
52-Week Low0.5
Moving Average 50 Days0.69
Moving Average 200 Days1.89

Statistics

Average Volume18,632
Shares Outstanding1.52M
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor83333:1000000
Last Split DateDecember 31, 2024